Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yvette Ng"'
Autor:
Yvette Ng, Mindy Chang, McKaylee Robertson, Christian Grov, Andrew Maroko, Rebecca Zimba, Drew Westmoreland, Madhura Rane, Chloe Mirzayi, Angela M. Parcesepe, Sarah Kulkarni, William Salgado-You, Nevin Cohen, Denis Nash
Objective: While much has been reported about the impact of the COVID-19 pandemic on food insecurity, longitudinal data and the variability experienced by people working in various industries are limited. This study aims to further characterize peopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d3143eee2b11c93bf19ac58a5745e4
Autor:
Yvette Ng, Mindy Chang, McKaylee Robertson, Christian Grov, Andrew Maroko, Rebecca Zimba, Drew Westmoreland, Madhura Rane, Chloe Mirzayi, Angela M. Parcesepe, Sarah Kulkarni, William Salgado-You, Nevin Cohen, Denis Nash
ObjectivesWhile much has been reported about the impact of COVID-19 on U.S. food insecurity, longitudinal data and the variability experienced by people working in different industries are limited. This study aims to further characterize individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac625f4059c10f7458f76eb42288aedd
https://doi.org/10.1101/2022.09.20.22280094
https://doi.org/10.1101/2022.09.20.22280094
Autor:
Joseph Ngaibi, Bigued, Antoine Kavaye Kandeda, Yvette Nguezeye, Tchang Alkali Wangbara, Lamido Gaoudji, Germain Sotoing Taiwe, Elisabeth Ngo Bum
Publikováno v:
Heliyon, Vol 10, Iss 20, Pp e39483- (2024)
Lippia multiflora Moldenke (Verbenaceae) is an aromatic plant used as a popular medicine with antidepressant, antispasmodic, antifungal, anti-inflammatory, and antioxidant properties. In this study, we explored the effects of L. multiflora in mice ch
Externí odkaz:
https://doaj.org/article/18de0b8f52cd4154b375a1f444f8b2d6
Autor:
Sabine Adeline Fanta Yadang, Yvette Nguezeye, Germain Sotoing Taiwe, Gabriel Agbor, Ur-Rahman Nisar, Elisabeth Ngo Bum
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S402- (2023)
Externí odkaz:
https://doaj.org/article/54efcdd29155453ea84368cfa7513528
Publikováno v:
Clinical genitourinary cancer. 15(2)
Background Our understanding of the clinical characteristics and treatment patterns of men who present with newly diagnosed metastatic (M1) hormone-sensitive prostate cancer is based mainly on clinical trial data. We sought to characterize the M1 pop
Autor:
Annette Lam, Tahamtan Ahmadi, Avinash Desai, Saad Z. Usmani, Yvette Ng, Ravi Potluri, Maneesha Mehra
Publikováno v:
The oncologist. 21(11)
BACKGROUND This retrospective study evaluated the treatment patterns in and overall survival (OS) of multiple myeloma (MM) patients who were refractory to a proteasome inhibitor (PI) and an immunomodulatory drug (IMiD) or who had received three or mo
Publikováno v:
Polymers, Vol 15, Iss 23, p 4471 (2023)
Ion bombardment is an important tool of materials processing, but usually leads to erosion of the surface and significant thickness reductions when thin layers are used. The growing use of polymer thin films in a variety of applications, from coating
Externí odkaz:
https://doaj.org/article/89a22f1c3ebb433e9074b1a643af36e5
Publikováno v:
Cancer Medicine
Despite increasing drug treatment options for metastatic castration‐resistant prostate cancer (mCRPC) patients, real‐world treatment data are lacking. We conducted retrospective analyses of commercial claims and electronic medical record (EMR) da
Autor:
Nicholas Yan Chai Cheung, Jasmine Lee Fong Fung, Yvette Nga Chung Ng, Wilfred Hing Sang Wong, Claudia Ching Yan Chung, Christopher Chun Yu Mak, Brian Hon Yin Chung
Publikováno v:
Human Genomics, Vol 15, Iss 1, Pp 1-11 (2021)
Abstract Background The global development and advancement of genomic medicine in the recent decade has accelerated the implementation of personalized medicine (PM) and pharmacogenomics (PGx) into clinical practice, while catalyzing the emergence of
Externí odkaz:
https://doaj.org/article/82e32e9ef951410ab0e5fa8c209055bd
Publikováno v:
Web of Science
Background: To fully evaluate the potential benefit of novel agents for the treatment of patients with multiple myeloma (MM) who are heavily pretreated and refractory, it is important to understand the outcomes of this patient population based on cur